StonvexLoading…
StonvexStonvexStonvexCore line items from GL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.56B | $5.99B | $4.47B | $2.96B |
Operating Income | $334.13M | $1.44B | $1.11B | $629.38M |
Net Income | $270.53M | $1.16B | $895.15M | $507.31M |
EPS (Diluted) | $3.39 | $14.07 | $10.77 | $6.07 |
Total Assets | $30.97B | $30.81B | $30.53B | $29.81B |
Total Liabilities | $24.88B | $24.84B | $24.84B | $24.39B |
Cash & Equivalents | $255.21M | $144.70M | $302.72M | $239.12M |
Free Cash Flow OCF − CapEx | $396.03M | $1.25B | $923.81M | $715.13M |
Shares Outstanding | 92.22M | 92.22M | 97.22M | 97.22M |